Reaction
Aortic Thrombosis reporting signals
As of the last recalculation, Aortic Thrombosis appears in 1,146 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is CISPLATIN (PRR 51.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cisplatin | 186 | 51.4 | 51.5 |
| Heparin Sodium | 29 | 39.3 | 39.3 |
| Bleomycin Sulfate | 13 | 23.1 | 23.1 |
| Gemcitabine Hydrochloride | 63 | 22.8 | 22.8 |
| Leucovorin Calcium | 21 | 20.3 | 20.3 |
| Gemcitabine | 42 | 20.1 | 20.1 |
| Amlodipine Besylate And Benazepril Hydrochloride | 9 | 17.8 | 17.9 |
| Fluorouracil Cream, 0.5% | 68 | 17.2 | 17.2 |
| Erlotinib | 9 | 17.0 | 17.0 |
| Fluorouracil | 68 | 16.9 | 16.9 |
| Cetuximab | 26 | 15.4 | 15.4 |
| Desloratadine | 9 | 15.4 | 15.4 |
| Pemetrexed | 17 | 14.6 | 14.6 |
| Erlotinib Hydrochloride | 9 | 13.2 | 13.2 |
| Etoposide | 49 | 12.6 | 12.6 |
| Testosterone | 15 | 11.8 | 11.8 |
| Pemetrexed Disodium | 23 | 11.2 | 11.2 |
| Aprepitant | 11 | 10.9 | 10.9 |
| Bicalutamide | 9 | 10.8 | 10.8 |
| Oxaliplatin | 41 | 10.4 | 10.4 |
| Testosterone Cypionate | 5 | 10.2 | 10.2 |
| Capecitabine | 40 | 8.2 | 8.2 |
| Fosaprepitant Dimeglumine | 6 | 8.0 | 8.0 |
| Carboplatin | 49 | 7.3 | 7.3 |
| Dabigatran Etexilate Mesylate | 27 | 6.9 | 6.9 |
| Dabigatran Etexilate | 27 | 6.4 | 6.4 |
| Alteplase | 5 | 6.1 | 6.1 |
| Pembrolizumab | 34 | 6.0 | 6.0 |
| Eltrombopag Olamine | 7 | 5.5 | 5.5 |
| Encorafenib | 3 | 5.5 | 5.5 |
| Drospirenone And Ethinyl Estradiol | 11 | 4.6 | 4.6 |